Noteworthy events during the week of October 6 – 12 for healthcare investors.
MONDAY (10/7): Alnylam Pharmaceuticals (NASDAQ:ALNY): Roundtable webcast – givosiran for acute hepatic porphyria.
Summit Therapeutics (NASDAQ:SMMT): R&D Day, NYC.
WEDNESDAY (10/9): European Academy of Dermatology and Venereology Congress, Madrid (5 days). XBiotech (NASDAQ:XBIT): Phase 2 data on bermekimab in atopic dermatitis.
THURSDAY (10/10): Alnylam Pharmaceuticals: Roundtable webcast: lumasiran for primary hyperoxaluria type 1.
SATURDAY (10/12): American Academy of Ophthalmology Annual Meeting, San Francisco (4 days). REGENXBIO (NASDAQ:RGNX): Phase 1/2a data on RGX-314 in wet AMD. Adverum Biotechnologies (NASDAQ:ADVM): Phase 1 24-week data on ADVM-022 in wet AMD. MeiraGTx Holdings (NASDAQ:MGTX): Phase 1/2 data on AAV-RPE65 in retinal dystrophy. Aldeyra Therapeutics (NASDAQ:ALDX): Data from Phase 3 ALLEVIATE study of reproxalap in allergic conjunctivitis.
https://seekingalpha.com/news/3504113-key-events-week-healthcare
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.